| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
phenotype | 0.900 | strong | 0.947 | 1 | 2 | 1995 | 2020 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
phenotype | 0.690 | strong | 1.000 | 1 | 5 | 2015 | 2019 | ||||||||
|
cytochrome c, somatic | 0.599 | 0.769 | 0.64 |
|
phenotype | 0.650 | strong | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.500 | strong | 0.968 | 1 | 3 | 1999 | 2019 | ||||||||
|
glycoprotein IX platelet | 0.695 | 0.500 | 0.48 |
|
phenotype | 0.460 | None | 1.000 | 1 | 1 | 1998 | 2020 | ||||||||
|
integrin subunit alpha 2b | 0.493 | 0.692 | 1.5E-16 |
|
phenotype | 0.450 | None | 1.000 | 1 | 1 | 1998 | 2019 | ||||||||
|
glycoprotein Ib platelet subunit beta | 0.524 | 0.769 | 0.51 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 2004 | 2019 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
phenotype | 0.400 | None | 1.000 | 1 | 3 | 1998 | 2020 | ||||||||
|
WASP actin nucleation promoting factor | 0.529 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 1 | 2002 | 2019 | ||||||||
|
ankyrin repeat domain 26 | 0.711 | 0.308 | 3.6E-24 |
|
phenotype | 0.200 | None | 1.000 | 1 | 2 | 2011 | 2019 | ||||||||
|
Fli-1 proto-oncogene, ETS transcription factor | 0.468 | 0.692 | 0.99 |
|
phenotype | 0.200 | None | 0.933 | 0 | 1 | 2000 | 2019 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 0 | 1 | 2005 | 2020 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.200 | None | 1.000 | 0 | 2 | 2002 | 2019 | ||||||||
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
phenotype | 0.140 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
phenotype | 0.130 | None | 1.000 | 0 | 2 | 2004 | 2017 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 0 | 1 | 2016 | 2019 | ||||||||
|
schlafen family member 14 | 0.931 | 3.5E-09 |
|
phenotype | 0.120 | None | 1.000 | 0 | 2 | 2015 | 2018 | |||||||||
|
cell division cycle 42 | 0.458 | 0.846 | 0.79 |
|
phenotype | 0.120 | None | 1.000 | 0 | 1 | 2015 | 2016 | ||||||||
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 0.610 | 0.692 | 2.5E-16 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2014 | 2019 | ||||||||
|
DNA ligase 4 | 0.478 | 0.846 | 4.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2001 | 2014 | ||||||||
|
signal transducer and activator of transcription 1 | 0.399 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | ||||||||
|
cholinergic receptor nicotinic epsilon subunit | 0.636 | 0.577 | 4.7E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
septin 5 | 0.691 | 0.462 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
clathrin light chain A | 0.628 | 0.654 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |